To contact us:

Your confidential marketplace for lab services and deals

Comparative major CROs according to their main capabilities:

Cuadro de texto: COMPARATIVE LIST OF MAJOR CROs:

Quintiles

It is the largest biopharmaceutical service company operating in more than 50 countries worldwide. It provides its full service model to biotechnology and pharmaceutical companies through four divisions comprising clinical development, healthcare consulting, partnerships and commercialization. It has helped to develop or commercialize all of the top 30 best-selling drugs.

 

Covance

Covance Inc. is the world’s second largest drug development services company operating in more than 20 countries and providing early stages of development such us toxicology in animals through clinical development to services supporting commercial market launch of drugs. Furthermore it provides laboratory testing services to the chemical, agrochemical and food industries. The company has the largest central laboratory network providing services to industries such as biotech, pharma, research, environmental, vaccines and food and dietary supplements.

 

PPD

Pharmaceutical Product Development (PPD) is the third largest CRO worldwide. It has offices in over 40 countries. PPD has two business segments, Discovery Sciences/Compound Partnering and Contract R&D. The Discovery Sciences segment offers biomarker discovery and patient sample analysis, compound partnering programs, and preclinical services, including preclinical program design, specialized preclinical oncology and diabetes models, toxicology consulting, laboratory services, and technical writing and regulatory submissions. The company specializes in oncology and diabetes preclinical modeling. The Development segment is divided in preclinical programs and clinical development covering bioanalytical analyses, laboratory services and product analysis, which include dissolution and stability studies. PPD is the second largest Phase II-IV CRO business. The company actively pursues an innovative drug co-development and risk sharing model through collaborative agreements with other companies to develop new compounds.

 

Charles River Laboratories

CRL is the largest supplier of animal research models and offers services in early stage drug development in the field of mammalian toxicology advancing the drug discovery and development process operating in countries including the US, Europe, Japan, Australia, Canada, China and Mexico. Key areas of expertise include transgenic animal technology, preconditioning services which include diet, aging, biological and chemical modification, vaccine support, in vitro methods for lot release testing of medical devices and injectable drugs, consulting and staffing services, toxicology studies, pathology services, discovery support, bioanalysis and drug metabolism.

 

PAREXEL

PAREXEL International is an outsourcing organization that operates in 43 countries including North America, Europe and the Asia-Pacific region, providing services on late-stage development, periapproval services, clinical trial management, data management, biostatistical analysis, medical writing, pharmacovigilance, medical marketing launches, market analysis, branding, and marketing communications services.  The consulting areas comprise regulatory affairs, clinical pharmacology, drug development, information technology, medical consulting, clinical benchmarking and performance improvement.  PAREXEL has an expertise in the central nervous system clinical trials, neuroscience drug development services and sleep studies.

 

MDS

MDS Inc. is a global life sciences company operating at least in 28 countries across North America, Europe, Africa, Asia Pacific and South America. It focuses on drug development and disease diagnosis supplying products and services such as radio therapeutics, medical isotopes for molecular imaging and analytical equipments for isotope-based cancer therapy. MDS Pharma Services is one of the two leading CROs with a focus on early clinical and bioanalytical research, providing contract research services from preclinical development to phase IIa clinical trials, bioequivalence, bioanalysis, global multicenter clinical trial management, centralized cardiac services and central labs for generic biopharmaceutical and drug delivery companies.

 

ICON

ICON plc. is a well established and renown provider of clinical research and drug development services operating over 30 countries throughout the world. ICON specializes in the management, execution and analysis of complex, multinational clinical trials in most major therapeutic areas. This company focuses almost exclusively  on late-stage drug development, specializing in the management of complex multinational and regional clinical trials, making it one of the very few CRO’s with the capability and expertise to conduct complex clinical trials on a global scale.

 

PharmaNet Development Group

PharmaNet Inc. is a global provider of outsourced R&D services across North and South America, Europe, Australia and Asia, including Japan and Singapore. They focus mainly on phase I and phase II through phase IV clinical trials, covering the entire spectrum of product development from early stage product planning and clinical development through late stage development and post-marketing support.

PharmaNet Development Group conducts clinical trials in all major therapeutic areas. It also offers bioanalytical services, including generic bioequivalence studies and complementary services such as data management and biostatistics, clinical laboratory services, medical and scientific affairs, regulatory affairs and submissions and clinical information technology services, establishing good communication with international regulatory bodies.

 

Kendle

Kendle International is a global CRO operating over 80 countries covering the regions of North America, Europe, Asia/Pacific, Latin America and Africa. Kendle is focused on large and multinational Phase I-IV clinical development programs in the top five therapeutic areas such as cardiology, oncology, antibiotics and antivirals, CNS and arthritis/inflammation. The company covers clinical data management, medical writing and regulatory affairs, providing customers with guidance on regulatory consulting and submission, validation and compliance and pharmacovigilance/safety services. More recently, Kendle is offering also a global biostatistics infrastructure.

 

LARGE CROs

Cuadro de texto: T h e   s m a r t e s t   w a y   t o   L a b o r a t o r y   O u t s o u r c i n g
Cuadro de texto: c o m

MAIN EXPERTISE

FIRST CHOICE CROs

ALTERNATIVE CROs

LABORATORY OUTSOURCING

MDS

 

CRL

 

PharmaNet

PPD

 

PRE-CLINICAL DEVELOPMENT

PPD

 

CRL

 

MDS

COVANCE

 

CLINICAL  TRIALS

QUINTILES

ICON

COVANCE

PPD

PAREXEL

PharmaNet

KENDLE

MARKETING COMMERCIALIZATION

 

QUINTILES

 

 

COVANCE

PAREXEL